SOFT-GELATIN CAPSULE FORMULATION
    2.
    发明授权
    SOFT-GELATIN CAPSULE FORMULATION 有权
    软明胶胶囊配方

    公开(公告)号:EP1978944B1

    公开(公告)日:2012-08-15

    申请号:EP07707560.4

    申请日:2007-01-23

    IPC分类号: A61K9/48 A61K31/5575

    摘要: The present invention discloses a soft gelatin capsule formulation of a 15-keto-prostaglandin compound, which comprises: a soft gelatin capsule shell comprising gelatin and sugar alcohol as a plasticizer, and a mixture comprising a 15-keto-prostaglandin compound and a pharmaceutically acceptable vehicle which is filled in the shell. By encapsulating the 15-keto-prostaglandin compound in the specified soft gelatin capsule shell, stability of the compound is significantly improved.

    摘要翻译: 本发明公开了15-酮 - 前列腺素化合物的软明胶胶囊制剂,其包含:包含明胶和糖醇作为增塑剂的软明胶胶囊壳,以及包含15-酮 - 前列腺素化合物和药学上可接受的 填充在壳体中的车辆。 通过将15-酮 - 前列腺素化合物包封在特定的软明胶胶囊壳中,化合物的稳定性显着提高。

    AQUEOUS COMPOSITION
    5.
    发明公开
    AQUEOUS COMPOSITION 有权
    WÄSSRIGEZUSAMMENSETZUNG

    公开(公告)号:EP1994933A1

    公开(公告)日:2008-11-26

    申请号:EP07738306.5

    申请日:2007-03-12

    申请人: R-Tech Ueno, Ltd.

    摘要: In an aqueous composition comprising a 15-keto-prostaglandin compound as an active ingredient, a polyoxyethylene castor oil derivative is admixed. By admixing a polyoxyethylene castor oil derivative, the solubility of the 15-keto-PG compound in water is increased. In a preferable embodiment, the aqueous composition may further comprise a quaternary ammonium type cationic surface active agent as a preservative. The composition of this embodiment exhibits high antimicrobial preservative effectiveness against indigenous bacterium in the eyes such as Staphylococcus aureus and therefore, the composition is especially useful as ophthalmic composition for ocular topical administration.

    摘要翻译: 在含有作为活性成分的15-酮 - 前列腺素化合物的水性组合物中,混合聚氧乙烯蓖麻油衍生物。 通过混合聚氧乙烯蓖麻油衍生物,增加了15-酮-PG化合物在水中的溶解度。 在优选的实施方案中,水性组合物还可以包含作为防腐剂的季铵型阳离子表面活性剂。 该实施方案的组合物对眼睛中的本土细菌如金黄色葡萄球菌表现出高抗微生物防腐效果,因此该组合物特别可用作眼部局部给药的眼用组合物。